Endogenous Opioid System: Acupuncture's Natural Analgesic Mechanism
Enkephalin, β-endorphin, and dynorphin release; μ/δ/κ receptor pharmacology; POMC; frequency-dependent selectivity; and the naloxone reversal proof.
How Does Acupuncture Activate the Endogenous Opioid System?
Dr. Kerem AL, a physician based in Izmir/Urla, Turkey, trained in Traditional Chinese Medicine in China, Taiwan, and Japan, integrates mechanistic understanding of endogenous opioid pharmacology with clinical acupuncture practice.
The endogenous opioid system consists of three families of opioid peptides — enkephalins, β-endorphin, and dynorphin — and three classes of G-protein-coupled opioid receptors (μ, δ, κ). Acupuncture is the most effective non-pharmacological method for mobilizing this system.
Needle insertion and mechanical stimulation activate A-delta afferent fibers, initiating a signaling cascade that reaches the spinal dorsal horn and supraspinal centers. In the spinal dorsal horn (Lamina II), proenkephalin-derived met-enkephalin and leu-enkephalin are released from inhibitory interneurons, activating μ and δ receptors to suppress C-fiber nociceptive transmission. In the midbrain PAG and hypothalamus, the POMC (proopiomelanocortin) system is engaged: POMC cleavage in the arcuate nucleus produces β-endorphin, which is the most potent endogenous opioid (18–33× more potent than morphine at μ receptors). β-endorphin release from the anterior pituitary also enters the systemic circulation, contributing to systemic analgesic, anxiolytic, and anti-inflammatory effects that outlast the acupuncture session by hours.
Electroacupuncture frequency determines the opioid peptide profile: 2 Hz preferentially releases enkephalins and β-endorphin (μ/δ receptors, vlPAG, chronic pain); 100 Hz preferentially releases dynorphin (κ receptor, spinal, acute pain). The naloxone reversal of acupuncture analgesia (Pomeranz & Chiu, 1976) remains the gold-standard proof of opioid receptor dependency.
Nörofizyolojik Mekanizma
Acupuncture needle → A-delta + C fiber activation → spinal dorsal horn enkephalin release (μ/δ receptors, Lamina II) + PAG/hypothalamus β-endorphin release (POMC, μ receptor) + spinal dynorphin (κ receptor) → Gi/Go protein coupling → adenylyl cyclase inhibition (↓cAMP) + GIRK K⁺ channel opening (hyperpolarization) + N-type Ca²⁺ channel inhibition (↓neurotransmitter release) → multilevel opioid analgesia
Önemli Klinik Noktalar
- 1Enkephalins (Met/Leu): spinal dorsal horn, μ and δ receptors; preferentially released by 2 Hz EA
- 2β-Endorphin: arcuate nucleus hypothalamus + anterior pituitary (POMC); μ receptor; longest duration; 2 Hz EA
- 3Dynorphin: spinal cord; κ receptor; faster onset, shorter duration; preferentially released by 100 Hz EA
- 4POMC cleavage also produces ACTH (adrenal axis) and α-MSH (anti-inflammatory): systemic anti-inflammatory effect
- 5Naloxone reversal: gold-standard experimental proof of opioid receptor dependency in acupuncture analgesia
- 6Dense-disperse 2/100 Hz: activates all three opioid systems simultaneously — maximum analgesic coverage
Three Endogenous Opioid Peptide Families
Each opioid peptide family derives from a distinct precursor protein, has a characteristic anatomical distribution, and preferentially activates a specific receptor subtype. Acupuncture activates all three families, with the relative contribution of each determined by stimulation parameters:
1. Enkephalins (Met-enkephalin and Leu-enkephalin)
Precursor:
Proenkephalin (PENK)
Receptor selectivity:
δ (primary) and μ opioid receptors
Primary localization:
Spinal dorsal horn (Lamina I, II, V), striatum, PAG
EA frequency:
2 Hz preferentially (3–4× increase, Han 2003)
Enkephalins are short-acting (rapidly degraded by enkephalinase/NEP) and act locally within the spinal dorsal horn. Microdialysis studies have directly measured enkephalin elevation in the spinal dorsal horn following acupuncture. Their pre-synaptic inhibition of C-fiber substance P release is the primary mechanism of spinal gate closure. δ-opioid receptor activation produces analgesia with notably lower tolerance development than μ-receptor activation, potentially explaining acupuncture's sustained efficacy with repeated use.
2. β-Endorphin
Precursor:
POMC (proopiomelanocortin) — shared with ACTH and α-MSH
Receptor selectivity:
μ opioid receptor (primary)
Primary localization:
Arcuate nucleus (hypothalamus), anterior pituitary, PAG, amygdala
Potency:
18–33× more potent than morphine at μ receptor
β-Endorphin is the most clinically significant opioid peptide in acupuncture analgesia. Its release from the anterior pituitary (adenohypophysis) into the systemic circulation explains the post-acupuncture feeling of profound relaxation, mood elevation, and analgesia that can last hours after the session ends. The arcuate nucleus of the hypothalamus is the primary brain source; POMC neurons here are activated by acupuncture stimulation via the spinohypothalamic tract. Serum and CSF β-endorphin measurements consistently show significant elevation following acupuncture.
3. Dynorphin
Precursor:
Prodynorphin (PDYN)
Receptor selectivity:
κ opioid receptor (primary)
Primary localization:
Spinal dorsal horn, hypothalamus, striatum
EA frequency:
100 Hz preferentially
Dynorphin and κ-receptor activation provide spinal analgesia with a faster onset than β-endorphin-mediated effects. κ-receptor activation also contributes sedation and anxiolysis, which may account for some of acupuncture's calming effects on the autonomic nervous system. Unlike μ and δ receptors (which produce euphoria), κ receptor activation does not create reinforcing/addictive behavioral effects, further supporting acupuncture's safety profile as a long-term pain management strategy.
POMC System: The Neuroendocrine Arm
POMC (proopiomelanocortin) is a large precursor protein cleaved into multiple bioactive peptides. Its name reflects the three peptide groups it contains: pro-opio-melano-cortin. Acupuncture increases POMC expression in the hypothalamic arcuate nucleus, producing multiple simultaneous therapeutic effects:
POMC-Derived Peptides and Their Roles
μ receptor agonist. Analgesic, anxiolytic, mood-elevating. Primary supraspinal opioid in acupuncture.
Adrenocorticotropic hormone. Stimulates adrenal cortex cortisol production. Acupuncture's anti-inflammatory and stress-regulating effect occurs partly via ACTH-mediated cortisol regulation.
Melanocyte-stimulating hormone. Anti-inflammatory action via melanocortin receptor (MC) activation. Suppresses pro-inflammatory cytokine production. Contributes to acupuncture's systemic anti-inflammatory effect.
The simultaneous release of β-endorphin (analgesia), ACTH (stress axis normalization), and α-MSH (anti-inflammation) from a single POMC precursor explains how a single acupuncture session can produce improvements across pain, mood, stress response, and inflammatory burden — a multi-target therapeutic profile unmatched by single-target pharmacology.
Opioid Receptor Pharmacology: μ, δ, and κ Systems
μ (Mu) Opioid Receptor (MOR)
Primary target for morphine and β-endorphin. Responsible for the majority of opioid analgesia. Expressed in the spinal dorsal horn, PAG, RVM, hypothalamus, and peripheral nerve terminals.
Signal transduction: MOR → Gi/Go protein → adenylyl cyclase inhibition (↓cAMP) → N-type Ca²⁺ channel inhibition (reduced neurotransmitter release at presynaptic terminal) + GIRK K⁺ channel opening (postsynaptic hyperpolarization). Net result: reduced nociceptive neuron excitability and reduced nociceptive neurotransmitter release from C-fiber terminals.
δ (Delta) Opioid Receptor (DOR)
Primary target for enkephalins. Spinal analgesia and mood modulation. MOR and DOR are often co-expressed in the same neuron (forming heterodimers), allowing enkephalin and β-endorphin to have synergistic effects at the same synapse.
Clinical relevance: DOR activation produces analgesia with substantially lower tolerance development than MOR activation. This may explain why acupuncture maintains analgesic efficacy over repeated sessions without diminishing returns — the δ-opioid component is resistant to desensitization by endogenous ligands at physiological concentrations.
κ (Kappa) Opioid Receptor (KOR)
Primary target for dynorphin. Spinal analgesia, sedation, diuresis, anxiolysis. Preferentially activated by 100 Hz electroacupuncture.
Key distinction from μ receptors: KOR agonists do not produce euphoria — unlike MOR agonists (which drive addictive behavior). This makes dynorphin-mediated analgesia pharmacologically safe for long-term clinical application. The sedative component of κ-receptor activation may contribute to the reduced cortisol and improved HRV (parasympathetic activation) observed after high-frequency electroacupuncture.
Frequency-Dependent Opioid Selectivity: 2 Hz vs 100 Hz
The research group led by Ji-Sheng Han at Peking University conducted landmark studies establishing that electroacupuncture frequency determines which opioid peptide family and receptor subtype is preferentially activated. This has direct clinical implications for protocol selection:
2 Hz — Low Frequency
- → Met/Leu-enkephalin release (spinal dorsal horn)
- → β-endorphin release (pituitary + arcuate nucleus)
- → μ and δ receptor activation
- → vlPAG-dominant supraspinal effect
- → Longer-lasting analgesia
- → Best for: chronic pain, fibromyalgia, depression, anxiety, insomnia
100 Hz — High Frequency
- → Dynorphin release (spinal cord)
- → κ opioid receptor activation
- → dlPAG-dominant supraspinal component
- → Faster onset, shorter duration
- → Sedation and anxiolysis more prominent
- → Best for: acute pain, post-operative pain, muscle spasm
Dense-Disperse Protocol (2/100 Hz)
Alternating 2 Hz and 100 Hz current in regular cycles simultaneously mobilizes enkephalin, β-endorphin, and dynorphin — activating all three opioid receptor subtypes (μ, δ, κ). This "dense-disperse" protocol provides maximum opioid analgesic coverage. Clinically useful for complex pain conditions requiring broad mechanism coverage (neuropathic pain, mixed pain syndromes, opioid-tolerant patients), and for reducing the risk of opioid receptor desensitization from sustained single-frequency stimulation.
Naloxone Reversal: The Definitive Experimental Proof
The opioid hypothesis of acupuncture analgesia rests on a robust experimental foundation. The most compelling evidence comes from pharmacological reversal studies using naloxone, a competitive opioid receptor antagonist:
Human Study (Pomeranz and Chiu, 1976)
The landmark study in human subjects demonstrated that intravenous naloxone (0.4–0.8 mg) administered after acupuncture substantially reversed the analgesic effect. In the same subjects, morphine analgesia was similarly reversed, confirming the shared opioid receptor mechanism. This study established acupuncture's opioid pharmacology on the same experimental footing as morphine.
Localization Studies (Animal Models)
Intrathecal (spinal) naloxone blocks enkephalin-mediated spinal inhibition; intracerebroventricular (ICV) naloxone blocks supraspinal β-endorphin-mediated analgesia (PAG level). This differential localization confirms that both spinal and supraspinal opioid circuits are engaged by acupuncture, operating through anatomically distinct but functionally integrated mechanisms.
μ-Opioid Receptor Knock-out Mice
Mice with genetic deletion of the μ-opioid receptor show approximately 70% reduction in acupuncture analgesia. The remaining 30% is attributed to δ and κ receptor activation and non-opioidergic mechanisms (GABAergic, serotonergic, noradrenergic pathways). This knockout model definitively establishes the μ-opioid receptor as the primary — but not exclusive — receptor for acupuncture analgesia, validating the multi-system model.
Frequently Asked Questions
Does acupuncture cause opioid dependence or addiction?
No. The key distinction between acupuncture-induced endogenous opioid release and exogenous opioid administration is one of quantity, localization, and receptor dynamics. Acupuncture triggers physiologically dosed, paracrine/neuroendocrine opioid release at specific synaptic sites — the released amounts remain within the physiological range where negative feedback mechanisms (receptor internalization, G-protein uncoupling) do not result in tolerance or dependence. Furthermore, enkephalins are rapidly inactivated by enkephalinase and angiotensin-converting enzyme, preventing accumulation. Long-term acupuncture patients show no behavioral signs of opioid dependence. Acupuncture additionally activates non-opioid pathways (serotonin, noradrenaline, GABA, dopamine) simultaneously, producing a balanced neurochemical state rather than the selective μ-receptor flooding associated with addictive behavior.
Does every acupuncture session produce the same opioid response?
No. Several factors modulate the magnitude of endogenous opioid release: (1) Stimulation intensity — adequate de qi sensation (heavy, distending, propagating feeling) correlates with sufficient A-delta fiber activation and proportional opioid mobilization; insufficient stimulation produces suboptimal results. (2) Frequency — 2 Hz versus 100 Hz produces different opioid peptide profiles as described above. (3) Duration — a minimum of 20–30 minutes of needle retention is required for adequate opioid peptide accumulation. (4) Patient baseline — chronic stress, sleep deprivation, and depleted baseline opioid tone reduce initial response magnitude; cumulative sessions progressively restore opioid system function.
How does acupuncture's opioid mechanism compare to opioid medications?
Exogenous opioids (morphine, oxycodone) non-selectively flood all μ, δ, and κ receptors throughout the central and peripheral nervous system, producing high-magnitude analgesia but also tolerance, dependence, respiratory depression, constipation, and addiction risk through receptor downregulation and neuroadaptation. Acupuncture produces localized, receptor-physiological opioid release: specific peptides, in appropriate concentrations, at defined anatomical sites (dorsal horn, PAG, hypothalamus), via paracrine rather than systemic distribution. This selectivity preserves receptor sensitivity, avoids systemic receptor flooding, and allows simultaneous activation of complementary non-opioid analgesic systems — producing clinically meaningful, sustained analgesia without the adverse profile of opioid pharmacotherapy.
Related Mechanism Pages
PAG Activation
vlPAG and dlPAG opioid columns, PAG-RVM axis, and descending serotonergic/noradrenergic inhibition.
Segmental Mechanism
Spinal dorsal horn enkephalin localization, gate control theory, and WDR neuron modulation.
How Acupuncture Works
Complete overview of acupuncture neurophysiology: opioid, autonomic, neuroinflammatory, and fMRI evidence.
Tıbbi İnceleme: Bu makale Dr. Kerem AL, MD tarafından gözden geçirilmiştir.
Dr. Kerem AL
Tıp Doktoru, Akupunktur Uzmanı
Eğitim: Gazi Üniversitesi Tıp Fakültesi
Uzmanlık: Geleneksel Çin Tıbbı, Akupunktur, Elektroakupunktur
Uluslararası Eğitim: Çin-Nanjing Üniversitesi, Tayvan-Taipei Şehir Hastanesi, Japonya-Kyoto özel klinik
Dr. Kerem AL, İzmir/Urla merkezli tıp doktoru. Geleneksel Çin tıbbı tanı perspektifi ile modern nörofizyolojik ağrı modülasyon modellerini entegre eder. Klasik meridyen teorisi, segmental etki, spinal dorsal horn modülasyonu ve PAG (Periaqueductal Gray) aktivasyonu konularında uzman.